Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus
1 other identifier
interventional
100
1 country
3
Brief Summary
An endoscopic third ventriculostomy is considered to be successful in idiopathic normal pressure hydrocephalus (iNPH) in some literature reports, but there is a lack of high quality data. The aim of the present study is to compare the treatment options of iNPH (Endoscopic third ventriculostomy versus ventriculo-peritoneal shunt) in a randomized, controlled, multicenter study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2016
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 31, 2017
CompletedFirst Posted
Study publicly available on registry
August 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedNovember 6, 2018
November 1, 2018
2.5 years
July 31, 2017
November 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Kiefer Index
Improvment of at least 2 points
1 year
Recovery Index
Improvment of at least 2 points
1 year
Study Arms (2)
endoscopic third ventriculostomy
EXPERIMENTALendoscopic third ventriculostomy for the treatment of iNPH
ventricular peritoneal shunt
ACTIVE COMPARATORInsertion of a ventriculo-peritoneal Shunt for the treatment of iNPH
Interventions
patients receive an endoscopic third ventriculotomy as surgical procedure
patients receive an ventriculo-peritoneal shunt as surgical procedure
Eligibility Criteria
You may qualify if:
- Age over 50 years
- gait disturbances typical for iNPH
- symptoms Duration less than 36months
- positive spinal TAP-test
You may not qualify if:
- no informed consent
- malignant disease
- other diseases of the CNS (Parkinson, dementia)
- secondary communicating hydrocephalus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University Medicine Göttingen
Göttingen, Germany
University Medicine Greifswald
Greifswald, 17489, Germany
Klinikum Neubrandenburg
Neubrandenburg, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 31, 2017
First Posted
August 10, 2017
Study Start
June 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2020
Last Updated
November 6, 2018
Record last verified: 2018-11